- 2026 Awardees
- 2025 Awardees
- 2024 Awardees
- 2023 Awardees
- 2022 Awardees
- 2021 Awardees
- 2020 Awardees
- Annual Reports
The Maryland Stem Cell Research Fund (MSCRF) is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in Maryland. Our Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. Since 2007, MSCRF has invested close to $200 million in accelerating stem cell research, cures and commercialization, in addition to building a collaborative stem cell community in our region. Discover how the Maryland Stem Cell Research Fund Accelerates Cures here.
Below is a list of our most current awardees.
2025
Engineering Human Mesenchymal Stem Cell-Derived Exosome Mimetics for Osteoporosis Treatment
2024
Developing and Improving Human Stem Cell-Derived Extracellular Vesicle Therapy for Brain Recovery After Cardiac Arrest
2021
Identification and Application of Distinct Perivascular Stem Cell Sub-Populations to Rotator Cuff Repair
2020
Developing Human iPSC-Derived Exosome Therapy to Improve Recovery after Peripheral Nerve Injury
Annual reports include profiles and details on past MSCRF awardees, the MSCR Commission, and closed grant awardees.